Caffeine, known to many as a stimulating component, can surprisingly have beneficial therapeutic properties. A recent study demonstrated its effectiveness in combating symptoms of depression and anxiety, thanks to its ability to reduce inflammatory processes in the brain. This encouraging conclusion was made by Brazilian scientists after a thorough analysis of numerous experiments on laboratory animals.
The researchers compiled a detailed systematic review that examined the effects of caffeine on the bodies of rodents. By studying the results of many experiments, they identified a clear pattern: caffeine consumption contributed to a noticeable reduction in stress signs in mice and rats. The results of their work were published in the peer-reviewed scientific journal Translational Psychiatry.
In their study, the Brazilian scientists selected 17 of the most significant scientific works, of which 6 were dedicated to anxiety disorders and 11 to depression issues. During the experiments, the researchers intentionally induced various mood and behavioral disorders in laboratory rodents.
The methods of stress provocation varied depending on the research goals. In some cases, the animals were subjected to acute stress situations, deprived of sleep, or frightened by the scent of predators. In other experiments, the rodents were kept under chronic stress conditions, such as being restricted in movement for several weeks. A bacterial toxin (lipopolysaccharide) was also used, which activated the rodents' immune systems, causing internal inflammation that led to depressive behavior.
After inducing a persistent stress state, the scientists administered caffeine to the rodents through drinking water or injections. Tests were then conducted: the animals were placed in mazes or open areas to assess their willingness to explore a new environment. Typically, anxious rodents hide in dark corners, while calmer individuals boldly explore open spaces.
The analysis results showed that caffeine had a positive effect on both anxiety disorders and depression. Rodents receiving caffeine showed a greater willingness to explore the surrounding world and performed better in tests. Moreover, caffeine helped the animals regain their lost motivation for activity.
The Brazilian researchers also studied the physical changes in the rodents' brains. They found that caffeine significantly reduced the levels of cytokines—proteins that cause inflammatory processes. By decreasing their concentration, caffeine mitigated the excessive immune system response in the brain.
Additionally, it was established that caffeine effectively combats oxidative stress in brain tissues. This process damages cell membranes, but caffeine not only slows it down but also enhances the antioxidant protection of brain cells.
Particularly significant was the discovery that caffeine reduces the activity of microglia—immune cells in the central nervous system. If these cells remain active for too long, they can begin to damage healthy areas of the brain.
In some studies, scientists compared the effects of caffeine with traditional antidepressants. It was found that caffeine exhibits effects similar to those of imipramine. The effectiveness of caffeine found in regular coffee and green tea extract, as well as in combination with chlorogenic acid, was also investigated. In all cases, a decrease in inflammatory protein levels and a reduction in depressive behavior in animals were observed.
Despite the promising results, the authors of the study noted several important limitations. The main issue is that most experiments were conducted on adult males, which does not allow for a complete assessment of caffeine's effects on females, young, or elderly individuals. It is known that stress affects different groups differently, and hormonal backgrounds can alter the body's response to stimulants. Additionally, different studies used varying dosages of caffeine, which is important to consider since overdose can be toxic and cause panic attacks in animals.
In conclusion, the Brazilian scientists emphasized the need for future research covering different age groups and sexes. Furthermore, a unified standard for caffeine dosages is required for objective comparison of results from various experiments. These measures are necessary to determine a safe and effective dose of the substance, as well as to fully understand the mechanisms of its influence on the brain.
The post Brazilian scientists revealed caffeine's ability to combat depression first appeared on the K-News website.
